Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study
Nutrients · 2025
DOI: 10.3390/nu17030516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Nasim Rezaee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Aust…. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Mitochondria, Sorghum. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edith Cowan University and Cwek Pty Limited.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with poorly understood pathology. Elevated tau, phospho-tau and mitochondrial dysfunction are significantly correlated with an increased risk of AD and are therefore targets for disease-modifying therapy. In this study, we examined the effects of polyphenolic extracts from six different varieties of sorghum: Shawaya short black-1 (Black), IS1311C (Brown), QL33/QL36 (Red), B923296 (Red), QL12 (White), and QL33 (Red) on the attenuation of beta amyloid-induced phospho-tau levels, total tau levels, and mitochondrial dysfunction in neuronal cells.
Method
Tau proteins (231 (pT231), Serine- 199 (pS199), and total tau proteins (T-tau)) were detected and quantified using sandwich ELISA kits, while mitochondrial dysfunction was measured in terms of mitochondrial membrane potential (Δψm) and adenosine triphosphate (ATP) levels.
Results
Almost all varieties of the sorghum extracts reduced the beta amyloid-induced pS199 and pT231 levels (p ≤ 0.05). The optimum concentration of QL33/QL36 (1000 µg/mL), QL12 (2000 µg/mL), and QL33 (2000 µg/mL) strongly attenuated the phospho-tau level. Sorghum IS1311C (750 µg/mL) showed the highest Δψm reduction (39.8%), whereas QL33 (2000 µg/mL) most strongly improved the ATP level (37.7%) (p ≤ 0.01). For both Δψm and ATP assays, the least activity was observed in sorghum B923296 at 21% and 25.5%, respectively (p ≤ 0.01).
Conclusions
The polyphenol extracts from sorghum attenuated the tau toxicity and Aβ-induced mitochondrial dysfunction in a variety- and dose-dependent manner and made a promising disease-modifying agent against AD. However, extensive research is needed to validate the efficacy of the sorghum extracts prior to animal and clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.
- Centre for Ageing, Health Future Institute, Murdoch University, Murdoch, WA 6150, Australia.
- Department of Biomedical Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- IngredientsbyDesign Pty Ltd., Lesmurdie, WA 6076, Australia.
- CWEK Pty Ltd., South Fremantle, WA 6162, Australia.
Förderung
- Edith Cowan University and Cwek Pty Limited
Zitieren
APA
Rezaee, N., Hone, E., Sohrabi, H., Abdulraheem, R., Johnson, S. K., Gunzburg, S., Martins, R. N., & Fernando, W. M. A. D. B. (2025). Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study. Nutrients. https://doi.org/10.3390/nu17030516
Vancouver
Rezaee N, Hone E, Sohrabi H, Abdulraheem R, Johnson SK, Gunzburg S, et al. Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study. Nutrients. 2025. doi:10.3390/nu17030516
BibTeX
@article{Rezaee2025,
author = {Rezaee, Nasim and Hone, Eugene and Sohrabi, Hamid and Abdulraheem, Rasheed and Johnson, Stuart K and Gunzburg, Stuart and Martins, Ralph N and Fernando, W M A D Binosha},
title = {Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17030516}
}
EUVIMED